Literature DB >> 15969302

The design of multicentre trials.

Valerii Fedorov1, Byron Jones.   

Abstract

The analysis of data collected in multicentre trials offers challenges because the data from the individual centres must be combined in some way to give an overall evaluation of the differences between the treatments in the trial. We propose that the combined response to treatment (CRT) be used as this overall measure. The definition and estimation of the CRT can be derived from either a fixed-effects or a random-effects model. For the latter we introduce the ECRT--the expected combined response to treatment. We describe and compare both types of model and express our preference for the random-effects model. We stress that the number of patients enrolled at a centre is a random variable and show that this source of randomness inflates the variance of the estimated ECRT. Variability in enrolment rates over the centres further inflates this variance. A simple conclusion from our results is that if variability in the treatment and centre effects, in the enrolment time, in the number of patients enrolled at a centre and in the enrolment rates is not properly accounted for, then an underpowered trial may result. Using properties of estimators generated by the random-effects model we propose methods for determining the optimal number of centres and total number of patients to enrol in a trial to minimize a loss function that accounts for centre and patient costs and loss of revenue. We discuss variants of the loss function and corresponding optimization problems for different types of enrolment. We end the paper with brief generalizations of the developed techniques to the case where the response is binary.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15969302     DOI: 10.1191/0962280205sm399oa

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  7 in total

1.  The Neuro/PsyGRID calibration experiment: identifying sources of variance and bias in multicenter MRI studies.

Authors:  John Suckling; Anna Barnes; Dominic Job; David Brennan; Katherine Lymer; Paola Dazzan; Tiago Reis Marques; Clare MacKay; Shane McKie; Steve R Williams; Steven C R Williams; Bill Deakin; Stephen Lawrie
Journal:  Hum Brain Mapp       Date:  2011-03-21       Impact factor: 5.038

2.  Comparing methods to estimate treatment effects on a continuous outcome in multicentre randomized controlled trials: a simulation study.

Authors:  Rong Chu; Lehana Thabane; Jinhui Ma; Anne Holbrook; Eleanor Pullenayegum; Philip James Devereaux
Journal:  BMC Med Res Methodol       Date:  2011-02-21       Impact factor: 4.615

3.  Sample size calculation in multi-centre clinical trials.

Authors:  Markus Harden; Tim Friede
Journal:  BMC Med Res Methodol       Date:  2018-11-29       Impact factor: 4.615

4.  Efficient and flexible simulation-based sample size determination for clinical trials with multiple design parameters.

Authors:  Duncan T Wilson; Richard Hooper; Julia Brown; Amanda J Farrin; Rebecca Ea Walwyn
Journal:  Stat Methods Med Res       Date:  2020-12-02       Impact factor: 3.021

5.  Estimating required information size by quantifying diversity in random-effects model meta-analyses.

Authors:  Jørn Wetterslev; Kristian Thorlund; Jesper Brok; Christian Gluud
Journal:  BMC Med Res Methodol       Date:  2009-12-30       Impact factor: 4.615

6.  Bayesian methods to determine performance differences and to quantify variability among centers in multi-center trials: the IHAST trial.

Authors:  Emine O Bayman; Kathryn M Chaloner; Bradley J Hindman; Michael M Todd
Journal:  BMC Med Res Methodol       Date:  2013-01-16       Impact factor: 4.615

7.  Mastering variation: variance components and personalised medicine.

Authors:  Stephen Senn
Journal:  Stat Med       Date:  2015-09-28       Impact factor: 2.373

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.